apon F & Barker J. Update on psoriasis immunopathogenesis and targeted immunotherapy.SeminImmunopathol. 2016 Jan;38(1):11-27. doi: 10.1007/s00281-015-0539-8. [13]. Horn EJ et al. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey.J Am Acad Dermatol. 2007;57:957-962. [14]. Armstrong A. et al. Under-treatment of patients with moderate to severe psoriasis in the United States: analysis of medication usage with health plan data.Dermatol Ther (Heidelb).2017 Mar; 7(1): 97–109. [15]. Hrehorow, E et al. (2012). Patients with psoriasis feel stigmatized,Acta Derm Venereol.92(1):67-72. doi:10.2340/00015555-1193. [16]. Armstrong A, Harskamp C & Armstrong E. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies.Nutr Diabetes.2013. Dec 3;2(12):e54. doi: 10.1038/nutd.2012.26. [17]. Dubertret L et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey.Br J Dermatol.2006 Oct;155(4):729-36. [18]. Oliveira, M., Rocha, B., & Duarte, G. V. Psoriasis: classical and emerging comorbidities.Anais brasileiros de dermatologia. Jan-Feb2015; 90(1), 9–20. https://doi.org/10.1590/abd1806-4841.20153038. [19]. Neimann A et al. Prevalence of cardiovascular risk factors in patients with psoriasis.J Am Acad Dermatol. 2006;55(5), 829–835. https://doi.org/10.1016/j.jaad.2006.08.040. [20]. Lebwohl MG et al. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.Am J Clin Dermatol. 2016 Feb;17(1):87-97. doi: 10.1007/s40257-015-0169-x. [21]. Lebwohl MG et al. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.J Am Acad Dermatol. 2014 May;70(5):871-81.e1-30. doi: 10.1016/j.jaad.2013.12.018. 来源:金色财经lg...